Journal ArticleOPEN ACCESS

Safety and Efficacy of AGN-190584 in Individuals With Presbyopia

  • Waring G
  • Price F
  • Wirta D
  • et al.
JAMA Ophthalmology (2022) 140(4) 363
DOI: 10.1001/jamaophthalmol.2022.0059
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

AGN-190584 (Allergan, an AbbVie company) is an optimized topical formulation of pilocarpine hydrochloride, 1.25%, designed for managing presbyopia and enhanced with a proprietary vehicle.

Cite

CITATION STYLE

APA

Waring, G. O., Price, F. W., Wirta, D., McCabe, C., Moshirfar, M., Guo, Q., … Robinson, M. R. (2022). Safety and Efficacy of AGN-190584 in Individuals With Presbyopia. JAMA Ophthalmology, 140(4), 363. https://doi.org/10.1001/jamaophthalmol.2022.0059

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free